The QuickVue iFOB test is an FDA-cleared and CLIA-waived rapid immunochemical diagnostic tool intended to detect the presence of blood in stool specimens. Blood in the stool is an indication of a number of gastrointestinal disorders, including colorectal cancer.
Blood in the stool is an indication of a number of gastrointestinal disorders, including colorectal cancer. Simply add six (6) drops of the buffered specimen solution into the cassette sample well and read the results in 5 to 10 minutes.
The QuickVue iFOB test requires only one specimen, and because it is specific to human hemoglobin, patients are not required to adhere to strict dietary or medication restrictions. The result is a more patient friendly test that is easier to complete and produces fewer false positives. Additionally, immunochemical FOB tests are more analytically sensitive than traditional Guaiac based methods. The QuickVue� iFOB test has the potential to increase patient compliance and offers superior analytical performance (as compared to Guaiac tests)3 to positively impact both patient care and satisfaction.